Weak Base Permeability Characteristics Influence the Intracellular Sequestration Site in the Multidrug-resistant Human Leukemic Cell Line HL-60*
暂无分享,去创建一个
Muralikrishna Duvvuri | Jeffrey P Krise | Yuping Gong | Dev Chatterji | J. Krise | Y. Gong | D. Chatterji | M. Duvvuri
[1] S. Pond,et al. Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin , 1996, Cancer Chemotherapy and Pharmacology.
[2] Y. Moriyama. Membrane energization by proton pumps is important for compartmentalization of drugs and toxins: a new type of active transport. , 1996, The Journal of experimental biology.
[3] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[4] D. Rickwood,et al. Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. , 1994, Analytical biochemistry.
[5] G. Capranico,et al. Anthracyclines: selected new developments. , 2001, Current medicinal chemistry. Anti-cancer agents.
[6] Richard P. Haugland,et al. Handbook of fluorescent probes and research chemicals , 1996 .
[7] C. Slapak,et al. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. , 1997, Blood.
[8] J. Modica-Napolitano,et al. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. , 2001, Advanced drug delivery reviews.
[9] K. Mills,et al. Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders , 1998, FEBS letters.
[10] Sanford M. Simon,et al. Intracellular pH and the control of multidrug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Girault,et al. Charge and Delocalisation Effects on the Lipophilicity of Protonable Drugs , 1999 .
[12] H. Rottenberg. The measurement of membrane potential and deltapH in cells, organelles, and vesicles. , 1979, Methods in enzymology.
[13] Muralikrishna Duvvuri,et al. Separate Roles for the Golgi Apparatus and Lysosomes in the Sequestration of Drugs in the Multidrug-resistant Human Leukemic Cell Line HL-60* , 2003, Journal of Biological Chemistry.
[14] Robin A. J. Smith,et al. Delivery of bioactive molecules to mitochondria in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Simon,et al. Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy , 1998, The Journal of experimental medicine.
[16] Muralikrishna Duvvuri,et al. A Cell Fractionation Approach for the Quantitative Analysis of Subcellular Drug Disposition , 2004, Pharmaceutical Research.
[17] V. Skulachev. Uncoupling: new approaches to an old problem of bioenergetics. , 1998, Biochimica et biophysica acta.
[18] P. Tulkens,et al. Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.